NVNO enVVeno Medical Corp

Price (delayed)

$8.96

Market cap

$6.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$25.12

Enterprise value

$3.78M

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 13
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 11

enVVeno Medical is an Irvine, California-based, clinical-stage medical device Company focused on the advancement of innovative bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of deep ...

Highlights
NVNO's debt is down by 43% YoY and by 16% from the previous quarter
The EPS has grown by 40% year-on-year and by 20% since the previous quarter
The equity has declined by 37% year-on-year and by 13% since the previous quarter
NVNO's quick ratio is down by 2.3% YoY and by 2.1% QoQ

Key stats

What are the main financial stats of NVNO

NVNO stock price

How has the enVVeno Medical stock price performed over time
Intraday
-1.54%
1 week
-0.99%
1 month
-12.93%
1 year
-73.16%
YTD
-20.21%
QTD
-16.34%

Financial performance

How have enVVeno Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.75M
Net income
-$15.72M
Gross margin
N/A
Net margin
N/A
enVVeno Medical's operating income has increased by 33% YoY and by 16% QoQ
enVVeno Medical's net income has increased by 32% YoY and by 16% from the previous quarter

Price vs fundamentals

How does NVNO's price correlate with its fundamentals

Growth

What is enVVeno Medical's growth rate over time

Valuation

What is enVVeno Medical stock price valuation
P/E
N/A
P/B
0.29
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 40% year-on-year and by 20% since the previous quarter
The price to book (P/B) is 76% lower than the 5-year quarterly average of 1.2 and 28% lower than the last 4 quarters average of 0.4
The equity has declined by 37% year-on-year and by 13% since the previous quarter

Efficiency

How efficient is enVVeno Medical business performance
NVNO's ROE is down by 9% year-on-year but it is up by 6% since the previous quarter
The company's return on assets fell by 6% YoY but it rose by 6% QoQ
The ROIC has grown by 4.2% from the previous quarter but it has contracted by 2.8% YoY

Dividends

What is NVNO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NVNO.

Financial health

How did enVVeno Medical financials performed over time
The company's total liabilities fell by 43% YoY and by 15% QoQ
enVVeno Medical's total assets has decreased by 38% YoY and by 13% from the previous quarter
NVNO's debt is 98% less than its equity
NVNO's debt is down by 43% YoY and by 16% from the previous quarter
The equity has declined by 37% year-on-year and by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.